These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3875804

  • 61. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
    Hartvig P, Lindquist NG, Aquilonius SM, d'Argy R, Bergström K, Bondesson U, Eckernäs SA, Gullberg P, Larsson BS, Lindberg B.
    Life Sci; 1986 Jan 06; 38(1):89-97. PubMed ID: 3484535
    [Abstract] [Full Text] [Related]

  • 62. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E, Youdim MB.
    Br J Pharmacol; 1985 Nov 06; 86(3):529-31. PubMed ID: 3877535
    [Abstract] [Full Text] [Related]

  • 63. Quantitative autoradiography of [3H]MPTP binding sites in rat brain.
    Wieczorek CM, Parsons B, Rainbow TC.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):453-4. PubMed ID: 6609829
    [No Abstract] [Full Text] [Related]

  • 64. Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP.
    Heikkila RE, Terleckyj I, Sieber BA.
    J Neural Transm Suppl; 1990 Mar 02; 32():217-27. PubMed ID: 2128498
    [Abstract] [Full Text] [Related]

  • 65. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G, Morissette M, Samadi P, Parent M, Di Paolo T.
    Biochem Pharmacol; 2013 Oct 01; 86(7):970-8. PubMed ID: 23954709
    [Abstract] [Full Text] [Related]

  • 66. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
    Ottoboni S, Caldera P, Trevor A, Castagnoli N.
    J Biol Chem; 1989 Aug 15; 264(23):13684-8. PubMed ID: 2788162
    [Abstract] [Full Text] [Related]

  • 67. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T, Arán VJ, Guillén H.
    Free Radic Res; 2009 Oct 15; 43(10):975-84. PubMed ID: 19669997
    [Abstract] [Full Text] [Related]

  • 68. Oxidation by rat brain of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) coupled to tetrazolium nitro blue.
    Youdim MB.
    Eur J Pharmacol; 1985 Jul 17; 113(2):283-6. PubMed ID: 3876227
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
    Ballard PA, Tetrud JW, Langston JW.
    Neurology; 1985 Jul 17; 35(7):949-56. PubMed ID: 3874373
    [Abstract] [Full Text] [Related]

  • 71. Accumulation of a parkinsonism-inducing neurotoxin in melanin-bearing neurons: autoradiographic studies on 3H-MPTP.
    Lindquist NG, Lydén-Sokolowski A, Larsson BS.
    Acta Pharmacol Toxicol (Copenh); 1986 Aug 17; 59(2):161-4. PubMed ID: 3490739
    [No Abstract] [Full Text] [Related]

  • 72. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
    Faucheux BA, Herrero MT, Villares J, Levy R, Javoy-Agid F, Obeso JA, Hauw JJ, Agid Y, Hirsch EC.
    Brain Res; 1995 Sep 11; 691(1-2):115-24. PubMed ID: 8590043
    [Abstract] [Full Text] [Related]

  • 73. Inhibition of [3H] MPTP binding to rat brain by pargyline.
    Del Zompo M, Bocchetta A, Piccardi MP, Pintus S, Corsini GU.
    Biochem Pharmacol; 1984 Dec 15; 33(24):4105-7. PubMed ID: 6334523
    [No Abstract] [Full Text] [Related]

  • 74. Distribution of 1-(3H)-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (3H-MPTP) in the frog: uptake in neuromelanin.
    Sokolowski AL, Larsson BS, Lindquist NG.
    Pharmacol Toxicol; 1990 Apr 15; 66(4):252-8. PubMed ID: 2371232
    [Abstract] [Full Text] [Related]

  • 75. Regional localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) uptake: mismatch between its uptake and neurotoxic sites.
    Takada M, Campbell KJ, Hattori T.
    Neurosci Lett; 1991 Nov 25; 133(1):137-40. PubMed ID: 1665214
    [Abstract] [Full Text] [Related]

  • 76. Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice.
    Sundström E, Jonsson G.
    Eur J Pharmacol; 1986 Mar 18; 122(2):275-8. PubMed ID: 3486769
    [Abstract] [Full Text] [Related]

  • 77. Brain enzyme is the target of drug toxin.
    Lewin R.
    Science; 1984 Sep 28; 225(4669):1460-2. PubMed ID: 6433484
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Monoamine oxidases of the brains and livers of macaque and cercopithecus monkeys.
    Riachi NJ, Harik SI.
    Exp Neurol; 1992 Feb 28; 115(2):212-7. PubMed ID: 1735467
    [Abstract] [Full Text] [Related]

  • 80. Immunohistochemical localization of monoamine oxidase-B in the cat brain: clues to understanding N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity.
    Schneider JS, Markham CH.
    Exp Neurol; 1987 Sep 28; 97(3):465-81. PubMed ID: 3305061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.